Abbvie Inc [ABBV] stock is trading at $233.91, down -1.12%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ABBV shares have gain 6.03% over the last week, with a monthly amount glided 9.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Abbvie Inc [NYSE: ABBV] stock has seen the most recent analyst activity on October 01, 2025, when HSBC Securities downgraded its rating to a Hold. Previously, Berenberg upgraded its rating to Buy on September 17, 2025, and kept the price target unchanged to $270. Daiwa Securities upgraded its rating to a Outperform but stick to its price target of $214 on August 07, 2025. Citigroup downgraded its rating to a Neutral but $205 remained the price target by the analyst firm on May 14, 2025. Cantor Fitzgerald started tracking with a Overweight rating for this stock on April 22, 2025, and assigned it a price target of $210.
Abbvie Inc [ABBV] stock has fluctuated between $163.81 and $244.81 over the past year. Currently, Wall Street analysts expect the stock to reach $240.33 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $233.91 at the most recent close of the market. An investor can expect a potential return of 2.74% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Abbvie Inc [NYSE:ABBV] reported sales of 58.33B for the trailing twelve months, which represents a growth of 6.65%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 1.42 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-385.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 232.13 points at the first support level, and at 230.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 237.26, and for the 2nd resistance point, it is at 240.62.
Ratios To Look Out For
For context, Abbvie Inc’s Current Ratio is 0.74. In addition, the Quick Ratio stands at 0.61 and the Cash Ratio stands at 0.16. Considering the valuation of this stock, the price to sales ratio is 7.08 and price to earnings (TTM) ratio is 111.32.
Transactions by insiders
Recent insider trading involved Richard A. Gonzalez, Former Director, that happened on Aug 22 ’25 when 62755.0 shares were purchased. Former Director, Richard A. Gonzalez completed a deal on Aug 21 ’25 to buy 90000.0 shares. Meanwhile, EVP, CHIEF OPERATIONS OFFICER SALEKI-GERHARDT AZITA sold 42370.0 shares on Aug 12 ’25.
